Jennifer Carter

PARTNER & VP VENTURE OPERATIONS

Jennifer brings over 25 years of experience in healthcare. Jennifer leads a team that works closely with portfolio companies to help identify and evaluate synergies across the McKesson ecosystem. In addition, the team develops perspectives on market insights relevant to McKesson Ventures’ investment focal areas.

Jennifer holds a B.S. in Economics from Boston College. Although born and raised in San Francisco, she spends harvest season on the family farm cultivating pluots and disrupting the plum and apricot industries.

Jennifer’s Investments: AspenRx Health, Augmedix, Lynx, Matternet, and Truveris

Cici Ceralde

DIRECTOR, PORTFOLIO DEVELOPMENT & VENTURE INSIGHTS

Cici brings a decade of consulting experience to her role in Venture Insights. Prior to joining McKesson Ventures, she worked at Slalom Consulting, focused on technology transformations and digital product strategies for healthcare and life sciences companies. Cici has spent her career championing forward-thinking technology and data approaches throughout the healthcare ecosystem.

Prior to Slalom, Cici was a director at Huron Consulting Group and worked with leading hospitals and health systems. Her consulting work focused on care delivery transformations and data and analytics strategies. Cici holds a B.S in Biology from Indiana University, Bloomington. In addition to reading about healthcare and technology for her role, Cici spends much of her free time reading for fun–everything from Homer and Shakespeare to histories and biographies to the latest science fiction novels.

Priyanka Kanal

SENIOR ASSOCIATE

Priyanka brings five years of life sciences consulting experience to the Investment team. Prior to joining McKesson Ventures, she was a manager at Accenture Strategy, advising large pharmaceutical companies on drug commercialization, product launch, and digital innovation. Priyanka is passionate about supporting and elevating underrepresented founders in the healthcare ecosystem.

Priyanka holds a B.S. in Economics and B.A. in Public Policy Studies from Duke University. She is a proud Blue Devil and avid traveler – ask her about her tenting experiences at Cameron Indoor Stadium and around the world.

Lizzie Lee

SENIOR ASSOCIATE

Lizzie brings over a decade of healthcare industry experience to her work at McKesson Ventures. She’s an advocate for the power of what novel startups and industry veterans can achieve together. Before joining the McKesson Ventures team, Lizzie helped launch and manage McKesson’s multi-year strategic growth initiative to position the business through long-term market disruption.

Prior to this, Lizzie was a consultant at ZS Associates where she worked with top life science companies on go-to-market strategy, launch planning and market access. She also helped build the firm’s innovation team. Lizzie earned her B.S. in Mechanical Engineering at Northwestern University. Outside of work, you can find Lizzie enjoying the outdoors by boat, skis, or even on foot.

Dave Schulte

PRESIDENT

Dave has been investing in healthcare technology and services businesses for more than two decades. He leads McKesson Ventures (MV) and previously led Kaiser Permanente Ventures. Dave is a graduate of St. John’s University and earned a Master of Public Policy from the Harvard Kennedy School.

Dave’s Active Investments: Aledade, Clinical Ink, HarmonyCares, IVX Health, Komodo, and Saama

Selected Exits: Curana Health (acquired by NEA), Landmark Health (acquired by Optum), OncoHealth (acquired by Arsenal), and SHYFT Analytics (acquired by Medidata)

Peter Lafer

HEAD OF GROWTH INVESTING

Peter brings over 15 years of healthcare investment and investment banking experience. Prior to joining McKesson Ventures, he was a Principal at General Atlantic (GA), a global growth equity firm, where he worked in both the Healthcare and Life Sciences groups and primarily focused on investments in biopharma services and life sciences tools. Prior to his time at GA, he was an investor at EW Healthcare Partners and began his career as an analyst in the Healthcare Investment Banking group at J.P. Morgan. He earned a BA from Duke and an MBA from Stanford Graduate School of Business. Peter lives in New York City with his wife, and outside of work enjoys going to see live music and theater.

Michelle Snyder

PARTNER

Michelle Snyder brings over 25 years’ healthcare industry experience in marketing, business development, strategic planning, public policy, and general management. Prior to joining McKesson Ventures, she was Chief Marketing Officer at Welltok as well as an early executive at Epocrates, where she worked for over a decade to build the company into one of the most recognized brands among clinicians.

Michelle has also served as an Executive-in-Residence at InterWest Partners, investing in digital health companies and advising portfolio companies. In addition, she has held consulting and policy positions at The Wilkerson Group, the Lewin Group and the Georgetown Center for Health Policy Studies.

Michelle earned her M.B.A. at the Kellogg School of Management at Northwestern University and her B.A. from Carleton College. Though she’s been in the Bay Area for over 20 years, she still dons green and gold and wears her Cheesehead proudly on Sundays.

Michelle’s Investments: Atropos Health, CancerIQ, Galileo, Inbound Health, Lumata Health, Midi, Reimagine Care, and RxVantage

Jack Wang

INSIGHTS MANAGER

Jack brings four years of life science strategy consulting experience to his role in Venture Insights. Prior to joining McKesson Ventures, Jack worked at ClearView Healthcare Partners and Red Nucleus, focusing on drug pricing strategy, commercialization, launch planning, and value message strategy. Jack is a graduate of University of Illinois at Urbana Champaign and has earned a Master of Translational Medicine from UC Berkeley and UCSF. Outside of work, Jack is an avid reader of both fiction and non-fiction. He is passionate about exploring interdisciplinary connections between industries, scientific disciplines, and humanities.

Carrie Hurwitz Williams

PARTNER

Carrie brings over 20 years of healthcare experience from several vantage points within the industry. She started her career in biopharma, managing clinical trials for oncology drugs. She then spent time in McKesson’s strategy and business development group before joining Omada Health, where she served as Vice President, Strategy and Business Development and focused heavily on all elements of commercial strategy. She then joined McKesson Ventures.

Williams earned her MBA from the Haas School of Business at the University of California at Berkeley and has a BS in biology from the University of Massachusetts Amherst. After more than a dozen years in the Bay Area, a piece of her heart will always be in San Francisco, but she is now back in the Boston area where she lives with her husband, daughters and their golden retrievers.

Carrie’s Active Investments: RxLightning, Mural Health, Evidation Health, Koneksa Health, Lambert Vet Supply, and Xealth

Selected Exits: Propeller Health (acquired by ResMed)

Jeff Seibert

EXECUTIVE ASSISTANT

Jeff has over 20 years of experience supporting executive teams and managing administrative functions for large departments. Jeff has a Bachelor of Arts degree from Fresno State University and is a native of Fresno as well. In Jeff’s spare time he provides Sarcasm as a Service (SaaS), is an average golfer at best, and works to keep us smiling.

Andrew Booth

CHIEF COUNSEL

Andrew brings over a decade of experience counseling investors and companies in venture capital transactions. Before joining McKesson, Andrew worked at DLA Piper, where he advised strategic and financial investors and acquirors and emerging growth companies in equity and debt financing, M&A and joint venture transactions in various industries, including healthcare, life sciences, and technology. Andrew received a B.A. from Duke University and J.D. from Washington University in St. Louis.

Tom Rodgers

MCKESSON EVP, CHIEF STRATEGY OFFICER

In 2014, Tom founded McKesson Ventures and built the program before moving into his current role as EVP and Chief Strategy Officer for McKesson in 2020. During his tenure at McKesson Ventures, Tom led investments in Accolade (ACCD), Aetion, Carena / Amwell (AMWL), ClearCare, Grail, Hims, and Pharmapacks, to name a few. Tom continues to oversee the program and the investment committee.